Levoketoconazole improves clinical signs and symptoms and patient-reported outcomes in patients with Cushing's syndrome.
Pituitary
; 24(1): 104-115, 2021 Feb.
Article
in En
| MEDLINE
| ID: mdl-33216275
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Cushing Syndrome
/
Ketoconazole
Type of study:
Diagnostic_studies
/
Prognostic_studies
Limits:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Pituitary
Journal subject:
ENDOCRINOLOGIA
Year:
2021
Type:
Article
Affiliation country:
United States